Technology Partnering


Micropoint is committed to discovering the world’s best biomarkers, antibodies, and technologies in order to develop them into rapid diagnostic systems. Accessing external innovation and expertise is a crucial part of our R&D strategy. Every scientist at Micropoint has a successful track-record of working closely with external partner companies and leading academic researchers around the world in key clinical diagnostic areas. Recent technology partnership ventures include:


  • A novel tumor biomarker clinical study with fluorescence-based RIDA technology

  • A compact, handheld MEMS based optical reader

  • A novel biomarkers study on our mLabs® platform

  • Transferring central lab ELISA test kits to our mLabs platform

  • Transferring qualitative lateral flow tests into quantitative

  • Customizing antibodies to mLabs

  • Advanced bio-signal amplification technologies


At Micropoint, we continue to maintain our network of collaborative and consultative relationships. We're committed to working with partners to provide novel diagnostics on demand, and have a track record of transforming key partnerships into rewarding, long-term strategic alliances. Contact us to learn more about our partnership programs and processes.



U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.